共 50 条
- [41] Phase II trial of nab-paclitaxel (ABI) and ipilimumab (ipi) in patients with treatment naive metastatic melanoma.JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)Ludford, KaysiaJohnson, Daniel H.Hennegan, TarinGruschkus, Stephen K.Haymaker, Cara L.Bernatchez, ChantaleJackson, NatalieHwu, PatrickDiab, Adi
- [42] RESULTS OF THE OPARATIC TRIAL: A PHASE I DOSE ESCALATION STUDY OF OLAPARIB IN COMBINATION WITH TEMOZOLOMIDE (TMZ) IN PATIENTS WITH RELAPSED GLIOBLASTOMA (GBM)NEURO-ONCOLOGY, 2017, 19 : 4 - 4Chalmers, AnthonyCruickshank, GarthDunn, LaurenceErridge, SaraGodfrey, LisaHerbert, ChristopherJefferies, SarahLopez, JuanitaMcBain, CatherinePittman, MarcSleigh, RebeccaWatts, ColinWebster-Smith, MarkHalford, Sarah
- [43] The clinical efficacy of combination of docetaxel and temozolomide in previously treated patients with stage IV melanomaMELANOMA RESEARCH, 2010, 20 (01) : 43 - 47Yoon, ChanPapadopoulos, Nicholas E.Camacho, Luis H.McIntyre, SusanAlvarado, Gladys C.Bedikian, Agop Y.Hwu, PatrickKim, Kevin B.
- [44] Results of the OPARATIC trial: A phase I dose escalation study of olaparib in combination with temozolomide (TMZ) in patients with relapsed glioblastoma (GBM).JOURNAL OF CLINICAL ONCOLOGY, 2017, 35Halford, Sarah E. R.Cruickshank, GarthDunn, LaurenceErridge, SaraGodfrey, LisaHerbert, ChristopherJefferies, SarahLopez, Juanita SuzanneMcBain, CatherinePittman, MarcSleigh, RebeccaWatts, ColinWebster-Smith, Mark F.Chalmers, Anthony J.
- [45] A single-arm phase II trial evaluating docetaxel, vinorelbine, and GM-CSF in stage IV melanoma.JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)Fruehauf, J. P.Eroglu, Z.Kong, K. M.Jakowatz, J. G.Akerley, W. L.Samlowski, W. E.
- [46] Phase II trial of combination thalidomide (thal) plus temozolomide (TMZ [TT]), in patients with metastatic malignant melanoma (MMM): Southwest Oncology Group S0508JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)Clark, J.Moon, J.Hutchins, L. F.Sosman, J. A.Kast, W. M.Da Silva, D.Liu, P. Y.Thompson, J. A.Sondak, V. K.
- [47] AN OPEN-LABEL MULTICENTER PHASE II TRIAL OF AVISCUMINE IN PREVIOUSLY TREATED PATIENTS WITH UNRESECTABLE STAGE IV METASTATIC MELANOMAEUROPEAN JOURNAL OF CANCER, 2015, 51 : S7 - S7Uwe, TrefzerRalf, GutzmerTabea, WilhelmFlorian, SchenckKatharina, Kaehler C.Volkmar, JacobiKlaus, WitthohnHans, LentzenPeter, Mohr
- [48] Final results of phase I/II study of decitabine (DAC) combined with temozolomide (TMZ) in metastatic melanoma (MM).JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)Beumer, J. H.Tawbi, H. A.Tarhini, A. A.Moschos, S. J.Egorin, M. J.Buch, S. C.Lin, Y.Kirkwood, J. M.
- [49] CHARLI: A phase Ib/II trial of ipilimumab-nivolumab-denosumab or nivolumab-denosumab in patients with unresectable stage III and IV melanoma.JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)Lau, Peter Kar HanHarris, Samuel JohnEastgate, Melissa A.Kee, DamienMant, AndrewNott, Louise M.Gedye, CraigInderjeeth, Andrisha JadeUnderhill, CraigWeppler, Alison MargaretWallace, RoslynLee, BelindaAu-Yeung, GeorgeWilliams, NarelleOspino, Daniel ArizaGonzales, LouiseShackleton, Mark J.Lo, Serigne N.McArthur, Grant A.Sandhu, Shahneen